SEC 13F Intelligence

Lion Point Capital, LP / BBIO

Lion Point Capital, LP’s Bridgebio Pharma Inc Position

Does Lion Point Capital, LP own Bridgebio Pharma Inc (BBIO)? Yes — 5.0K shares worth $371,300 (+2.22% of its 13F portfolio) as of Q1 2026.

Position Value
$371,300
Q1 2026
Shares
5.0K
% of Portfolio
+2.22%
Quarters Held
8
currently held

Position History BBIO

Reported value by quarter
Q2 ’24: $1MQ2 ’24Q3 ’24: $1MQ3 ’24Q4 ’24: $1MQ4 ’24Q1 ’25: $898,820Q1 ’25Q2 ’25: $1MQ2 ’25Q3 ’25: $690,802Q3 ’25Q4 ’25: $382,450Q4 ’25Q1 ’26: $371,300Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.0K$371,300+2.22%
Q4 20255.0K$382,450+1.98%
Q3 202513.3K$690,802+3.92%
Q2 202526.0K$1M+7.62%
Q1 202526.0K$898,820+5.73%
Q4 202440.3K$1M+5.79%
Q3 202449.0K$1M+2.78%
Q2 202449.0K$1M+2.26%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of BBIO.